Abstract: Designed armadillo repeat proteins (dArmRP) are a-helical solenoid repeat proteins with an extended peptide binding groove that were engineered to develop a generic modular technology for peptide recognition. In this context, the term "peptide" not only denotes a short unstructured chain of amino acids, but also an unstructured region of a protein, as they occur in termini, loops, or linkers between folded domains. Here we report two crystal structures of dArmRPs, in complex with peptides fused either to the N-terminus of Green Fluorescent Protein or to the C-terminus of a phage lambda protein D. These structures demonstrate that dArmRPs bind unfolded peptides in the intended conformation also when they constitute unstructured parts of folded proteins, which greatly expands possible applications of the dArmRP technology. Nonetheless, the structures do not fully reflect the binding behavior in solution, that is, some binding sites remain unoccupied in the crystal and even unexpected peptide residues appear to be bound. We show how these differences can be explained by restrictions of the crystal lattice or the composition of the crystallization solution. This illustrates that crystal structures have to be interpreted with caution when protein-peptide interactions are characterized, and should always be correlated with measurements in solution.
Introduction
Natural armadillo repeat proteins (nArmRP) are asolenoid proteins which bind to unstructured regions of their targets in processes of signal transduction or nuclear transport. Each armadillo repeat is composed of 42 residues 1 that fold into three helices (H1, H2, and H3) in a triangular arrangement. The stacked repeats, capped at both termini with special repeats to protect the hydrophobic core from solvent exposure, build up a continuous superhelical domain with an extended peptide-binding groove defined by the adjacent H3 helices. [2] [3] [4] [5] These proteins possess an intrinsically conserved modular binding mode towards peptides. Upon complex formation, the peptide and the nArmRP form a complex where the N-to C-terminal directions of peptide and protein are antiparallel. Peptides are bound in an extended conformation, and the peptide main chain of every second residue is fixed in a b-strand conformation by two hydrogen bonds with conserved asparagine residues (N 37 , superscripted numbers refer to positions within one repeat) on the H3 helices. The specificity for the peptide sequence is mediated by contacts to the peptide side chains, and modularity is ensured, since each repeat binds two residues of the peptide. 3, [6] [7] [8] [9] [10] Designed armadillo repeat proteins (dArmRP) were engineered based on natural armadillo repeat proteins (nArmRP) by consensus design and computational optimization of the hydrophobic core, 11 molecular dynamics simulations to further improve thermodynamic stability, 12 and rational engineering of the N-terminal capping repeat based on crystal structures. 13 The final construct, called Y III M x A II (the roman numbers indicate the design cycle of the caps, x stands for the number of internal repeats), is monomeric, has high expression yields in E. coli, improved biophysical stabilities compared to nArmRP, and adopts the expected solenoid fold. 13 An overview of all engineering steps is given in Ref. 14. Our goal is to develop a generic detection technology based on dArmRP for any unstructured peptide sequence, especially in the context of unstructured regions of folded proteins. Such a technology would significantly speed up the process of creating affinity reagents against linear epitopes as signature sequences of given proteins. dArmRPs are especially suited as a scaffold for such a technology since they are formed by several repeats that stack on one another, allowing facile modification of the length of the binding groove by introduction or omission of repeats. Furthermore, they adopt more uniform super-helical curvatures than the more irregular nArmRP, which thus allows binding of longer peptide stretches. [13] [14] [15] [16] Previously, we described the first structure and detailed characterization of the high-affinity interaction between Y III M x A II and peptides made of alternating lysine and arginine residues ((KR) n ). This study showed that our design exhibited the expected characteristics of a modular peptide binder. The binding affinity was modulated by changing the length of the interaction partners and a first Y III M 5 A II :(KR) 5 complex structure (between dArmRP and a synthetic peptide, PDB ID: 5AEI) revealed almost the same interactions in each dipeptide:protein-repeat unit. The regularity was disturbed only by a crystal contact between symmetryrelated peptides. 16 Here we present structural evidence that dArmRP cannot only interact with synthetic peptides but also with unstructured regions of folded protein domains in a very similar manner. Two highresolution structures are presented, one of Y III M 5 A II interacting with a N-terminal fusion of (KR) 4 5 , the complex structure with the unfused peptide, shows that the peptide is less regularly bound in Y III M" 6 A II :pD_(KR) 5 . Furthermore, the four Y III M" 6 A II :pD_(KR) 5 complexes from the AU are not identical as they exhibit different positions of the pD-domain relative to the dArmRP, which puts strain on the peptide and thereby influences peptide binding. The orientation in complexes CD and GH is better suited for the peptide to bind to the binding groove. In complexes AB and EF, the C-terminus of the pD-domain to which (KR) 5 is fused is positioned further away from the binding groove than in complexes CD and GH; as a consequence, not the entire peptide is bound in AB and EF [ Fig. 3(C) ]. Therefore, only two and three (complex EF and AB, respectively) out of ten possible conserved bidentate hydrogen bonds between N 37 and the peptide backbone are formed (distance cutoff: 3.6 Å ). In complexes CD and GH, the positioning of the (KR) 5 peptide is closer to the binding groove, but also here only five out of the ten possible hydrogen bonds between N 37 and peptide backbone are formed (distance cut-off: 3.6 Å ). This result shows that in all complexes strain is applied to the peptide by the pD-fusion, which has to fit into the crystal lattice. Analysis of the binding interface between (KR) 5 5 , antiparallel binding is also established, but as mentioned above, only few N 37 s are involved in binding, and especially some lysine side chains point away from the binding surface. In all complexes, the first (KR) dipeptide, closest to pD, interacts mainly with residues of dArmRP internal repeats four and five. This means that dArmRP internal repeat six does not contribute to binding at all and consequently the C-terminal (KR) dipeptide of (KR) 5 is overhanging towards the N-cap of the dArmRP, and thus not resolved in the electron density. 
Structure of Y III M 5 A II :(KR) 4 _sfGFP
The complex structure between Y III M 5 A II and (KR) 4 _sfGFP was determined at 2.4 Å resolution. Crystallization condition, data collection and refinement statistics are reported in Table III . The AU contains two 1:1 complexes [ Fig. 4(A) ]. To avoid negative residue numbers in the peptide that was fused Nterminally to sfGFP but still stay close to the common numbering convention of GFP (the chromophore is formed from residues 64-66) we added 1000 to all residues of (KR) 4 _sfGFP. The (KR) 4 peptide is bound by Y III M 5 A II via its designated binding groove in the expected antiparallel orientation [ Fig. 4 5 , even though they constitute KR pairs, since the two linker residues, Gly998 and Glu997, also have to be accommodated. This is achieved by a sharp kink of the peptide backbone at this position. Gly998 interacts with N 37 (Asn121), while Glu997 occupies the arginine binding pocket formed by Trp117 and Trp159. This is at first surprising, considering the opposite charges of Glu997 and arginine, but crystals were obtained at a pH value of 4.6. Hence, Glu997 can be regarded as protonated and Glu156 (labeled as E 30 in the figure), which usually forms a salt bridge with an arginine, flips its side chain away from the pocket [ Fig. 4(D) ]. Because Glu997 occupies an arginine binding pocket, the neighboring Arg996 occupies the lysine binding pocket. This behavior is seen for all residues towards the N-terminus, meaning that all lysines bind in the arginine pockets and vice versa [ Fig. 4(D) ]. The peptide adopts the expected backbone binding mode forming bidentate main chain interactions with N 37 . Only the H-bonds between Asn247 and LysK991 are stretched (3.8 Å for Asn247-OD. . .Lys991-N and 3.6 Å for Asn247-ND. . .Lys991-O). Because of the register shift, the N 37 hydrogen bonds fix the backbone of . Because a substantial part of the binding groove is occupied by the linker, the N-terminus of (KR) 4 is pointing toward the C-terminus of the dArmRP [ Fig. 4(D) ].
Complex CD is similar to complex AB with essentially the same interactions. However, the whole ArmRP is shifted relative to the peptide by one repeat toward the peptide C-terminus. This means that in complex AB internal repeats one to five interact with the peptide, whereas in the case of complex CD, internal repeats two to five bind the peptide, one repeat less than in complex CD [ Fig. 4(B) ]. Hence, a larger portion of the peptide is overhanging at the Cterminus of the dArmRP in complex CD, compared to complex AB, and the first residue K989 is not resolved in the electron density map. The observation of a shift by one repeat relative to the peptide is not unexpected, since the internal repeats all have exactly the same sequence and are capable of interacting in the same way. However, two different registers have not been observed within the same X-ray structure before.
Affinities of (RR) 4 and (KK) 4 peptides
In the structure of Y III M 5 A II :(KR) 4 _sfGFP the lysine/ arginine recognition of the peptides is flipped; arginines bind to lysine pockets whereas lysines bind to arginine pockets. To estimate the effect of this flipping, affinities of (RR) 4 and (KK) 4 peptides with Y III M 4 A II and Y III M 5 A II were determined. This ensures that all pockets are occupied by the same residues, either lysine or arginine, and the comparison with the affinities of (KR) 4 peptides allows to quantify the effect of either residue bound in the opposite pocket. (RR) 4 is bound more tightly by both dArmRP than (KR) 4 while the affinity of (KK) 4 is much weaker than (KR) 4 (Table  II) . Hence, arginines bind better than lysines in both pockets. A flipped peptide where arginines take the usual place of lysines and vice versa will still possess a reasonable affinity, probably in between the affinities of (KR) n and (KK) n peptides.
Discussion
Here we present structural evidence that dArmRPs are able to bind unstructured peptide stretches connected to folded protein domains, and not just synthetic peptides. The general binding mode of Y III M x A II and (KR) n was thus confirmed, meaning that the interaction is indeed mediated by the designated binding groove and the expected topology of the complex is adopted. This topology is defined by the directions of the N-and C-termini, which run in opposite directions for dArmRP and peptide (antiparallel complex). The conservation of this topology is crucial for the prediction of binding epitopes based on the primary peptide sequence and hence for the modular concept of the dArmRP technology.
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Structures obtained by X-ray crystallography are usually taken as gold standard to which all other data have to be compared. Here we have observed, however, differences between the interactions of the fused peptide with the dArmRP even within the same unit cell, emphasizing the need for a more critical evaluation of such interactions. In some cases relevant intermolecular contacts can be disfavored because of the strong forces generated when accommodating packing contacts. 21 The observed structure(s) are in an energy minimum accommodating these crystal packing interaction, the cognate peptide-protein interactions, and any other interaction within and between molecules.
The interaction between dArmRPs and (KR) n has been described in-depth by in-solution methods and a structure of the complex with the unfused peptide, Y III M 5 A II :(KR) 5 , has been determined that is only marginally influenced by crystal packing. 16 In contrast, both structures described here exhibit some striking differences from the expected behavior in solution. These differences could be attributed to dynamics of the interaction between dArmRP and peptide. However, some changes in occupancy are likely caused by the formation of the crystal lattice. Notably the Y III M" 6 A II :pD_(KR) 5 structure consists of eight dArmRPs and only four pD_(KR) 5 chains. On the atomic level the (KR) 5 peptides interact with only one dArmRP chain. Hence, in the crystal we find only half of the dArmRPs occupied by a peptide, forming four 1:1 complexes and four unoccupied dArmRPs, while in solution, homogenous 1:1 complexes are observed by SEC-MALS [ Fig. 1(A) , Table  I ]. It is stunning that despite the high affinity of this interaction half of the peptide binding sites on dArmRPs remain unoccupied in the crystal structure. Probably, a crystal lattice with a homogenous distribution of 1:1 complexes could not be obtained. Also the four dArmRP molecules that form a direct interaction with pD_(KR) 5 show different arrangements of the pD domain and dArmRP relative to each other. This influences the observed peptidedArmRP interaction; the interactions are more similar to the unfused peptide complex Y III M 5 A II :(KR) 5 when the C-terminus of pD_(KR) 5 is positioned closer to the peptide binding groove of the dArmRP [ Fig. 3(D) ] and thus fewer spatial restrictions are imposed on the peptide. This shows that the crystal lattice has a profound influence on the observed interaction in the experimental structures.
Y III M" 6 A II :pD_(KR) 5 was the first structure determined of an M-type repeat in complex with a peptide. In the M-type repeat two point mutations were introduced that were thought to increase the affinity to (KR) n peptides. However, this was not achieved, K d s are even slightly weaker compared to the M-type repeats (Table II) , probably due to a less optimal binding geometry.
The structure of Y III M 5 A II :(KR) 4 _sfGFP shows that the dArmRP also interacts with the linker between (KR) 4 and sfGFP, which has the sequence EGKL. This would seem to put the specificity towards the (KR) n peptides in question. We believe, however, that this observed binding is only possible at low pH, where a protonated E997 can be accommodated in an arginine pocket. The conformation where the linker is bound has probably a reduced flexibility compared to a conformation where the linker is not stabilized by the dArmRP, and thus might benefit crystal formation. In solution, no measurable affinity was observed between (AV) n peptides that were fused with exactly the same linker sequence to sfGFP, 16 pointing to no relevant affinity of the linker region itself to Y III M 5 A II . Two different binding registers are found within one structure. We already proposed this behavior as a possible cause for the high affinity between Y III M x A II and (KR) n , because it would increase the configurational entropy of the complexes. 16 It was previously reported that in a dataset of protein-ligand complex structures around one third of the entries exhibit influences on the binding mode of ligands by crystal contacts. 22 In the structures described here, a flexible peptide is bound, and residual binding affinity will be preserved even if it is only partially bound or flipped. Therefore, these structures might be especially susceptible to influences on their observed interaction mode. The fusion to a bulky structured domain adds to this problem because energetically it might be more valuable to accommodate this domain in the crystal lattice rather than establishing the full-length interaction of the flexible epitope. 21 Finally, the high salt con- 4 _sfGFP) of the crystallization conditions reduce the affinities of (KR) n peptides to dArmRP. 16 In summary, even though the two structures described here confirm the general binding mode of dArmRP for target peptides in the context of folded protein domains, we show how packing of crystals or crystallization conditions can elicit deviations from the behavior in solution. Hence, we want to stress that interaction studies by protein crystallization should be corroborated by suitable in-solution experiments.
Methods

Cloning
Cloning of the dArmRP genes has been described previously. 13 For SEC-MALS and crystallization, they were subcloned with BamHI and HindIII restriction enzymes (FastDigest enzymes, Fermentas) into the vector pQE30LIC_3C, which contains a MRGSHis 6 -tag cleavable by 3C-protease. 16 For fluorescence anisotropy experiments, dArmRP genes were cloned into the expression vector pQIq containing an uncleavable N-terminal MRGSHis 6 tag. 23 Cloning of (KR) 4 _sfGFP and pD_(KR) 5 has been described previously. 16 For crystallization they were also subcloned into the vector pQE30LIC_3C. Plasmids were extracted from overnight cultures of single E. coli XL1 Blue colonies grown on LB agar plates (100 mg mL 21 ampicillin as selection marker) and sequenced. E. coli XL1 Blue or E. coli BL21 (DE3) cells were retransformed with plasmids with correct sequences, and glycerol stocks (20% glycerol, stored at 2808C) were made.
Protein expression and purification
Protein expression was carried out in 1 l of 2xYT medium (containing 100 mg L 21 ampicillin and 0.5% glucose). Media were inoculated from 25 mL overnight culture, themselves inoculated from glycerol stocks, and grown at 378C to an OD 600 of 0.7. Expression was induced by adding 750 mM of isopropyl-b-D-thiogalactopyranoside (IPTG) and left for 5 h at 378C. Cells were harvested by centrifugation (5000 g, 5 min), resuspended in 25 mL TBS_W (50 mM Tris pH 8.0, 400 mM NaCl, 20 mM imidazole) and frozen until further usage. Resuspended cells were thawed on ice and lysed by sonication and passage through a French press system, cell debris was removed by centrifugation (25,000g, 20 min where Y is the actual amplitude, m is the amplitude of maximal anisotropy increase, K D is the dissociation constant, L t is the total ligand concentration (dArmRP), and R t is the total receptor concentration (peptide-sfGFP).
Crystallization and structure determination
Sparse-matrix screens (Hampton Research and Molecular Dimensions) in 96-well Corning plates (Corning Incorporated) at 48C were used in a sitting-drop vapor diffusion set-up to identify initial crystallization conditions. For each condition the reservoir solution was mixed in three ratios with protein solution (1:1, 1:2, and 2:1). Table III summarizes the crystallization conditions as well as data collection and refinement statistics. Crystals of Y III M 5 A II :(KR) 4 _sfGFP were flashfrozen (liquid N 2 ) in mother liquor supplemented with 20% glycerol, whereas crystals of Y III M" 6 A II :pD_(KR) 5 were frozen directly in mother liquor. Data of Y III-M 5 A II :(KR) 4 _sfGFP was collected on beam line X06DA at the Swiss Light Source (Paul Scherrer Institute, Villigen, Switzerland) using a Pilatus detector system (Dectris). Data of Y III M" 6 A II :pD_(KR) 5 was collected at beamline P14 at Petra III (Deutsches Elektronen Synchotron, Hamburg) on a Pilatus detector system (Dectris). Data were processed using programs XDS, XSCALE and XDSCONV. 24 
PHASER
25 was used for molecular replacement to obtain initial phases. Search models for Y III M 5 A II :(KR) 4 _sfGFP were poly-alanine-models based on PDB IDs 5AEI (dArmRP, chain A) and 1GFL (GFP, chain A). For Y III M" 6 A II :pD_(KR) 5 a model based on structure 5AEI but with six internal repeats was used as search model for dArmRPs. This allowed us to obtain initial phases and subsequent manual placement of PDB-ID: 1TCZ 18 into the additional density. Refinement was done using programs REFMAC5, 26, 27 BUSTER, 28 and Phenix-Refine, 29, 30 followed by model building in COOT. 31, 32 Five percent of data were used to calculate the R free value.
